Logo image of AEVA

AEVA TECHNOLOGIES INC (AEVA) Stock Fundamental Analysis

NASDAQ:AEVA - Nasdaq - US00835Q2021 - Common Stock - Currency: USD

27.55  +1.73 (+6.7%)

Fundamental Rating

4

Taking everything into account, AEVA scores 4 out of 10 in our fundamental rating. AEVA was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. AEVA has a great financial health rating, but its profitability evaluates not so good. AEVA is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AEVA had negative earnings in the past year.
In the past year AEVA has reported a negative cash flow from operations.
AEVA had negative earnings in each of the past 5 years.
In the past 5 years AEVA always reported negative operating cash flow.
AEVA Yearly Net Income VS EBIT VS OCF VS FCFAEVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

Looking at the Return On Assets, with a value of -132.52%, AEVA is doing worse than 93.60% of the companies in the same industry.
Looking at the Return On Equity, with a value of -220.60%, AEVA is doing worse than 92.80% of the companies in the same industry.
Industry RankSector Rank
ROA -132.52%
ROE -220.6%
ROIC N/A
ROA(3y)-67.52%
ROA(5y)-60.44%
ROE(3y)-87.76%
ROE(5y)-76.12%
ROIC(3y)N/A
ROIC(5y)N/A
AEVA Yearly ROA, ROE, ROICAEVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AEVA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AEVA Yearly Profit, Operating, Gross MarginsAEVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

More info and screens

8

2. Health

2.1 Basic Checks

AEVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AEVA has more shares outstanding
AEVA has more shares outstanding than it did 5 years ago.
There is no outstanding debt for AEVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AEVA Yearly Shares OutstandingAEVA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
AEVA Yearly Total Debt VS Total AssetsAEVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

AEVA has an Altman-Z score of 7.42. This indicates that AEVA is financially healthy and has little risk of bankruptcy at the moment.
AEVA has a better Altman-Z score (7.42) than 85.60% of its industry peers.
AEVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 7.42
ROIC/WACCN/A
WACC9.1%
AEVA Yearly LT Debt VS Equity VS FCFAEVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 2.88 indicates that AEVA has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.88, AEVA is in the better half of the industry, outperforming 61.60% of the companies in the same industry.
AEVA has a Quick Ratio of 2.76. This indicates that AEVA is financially healthy and has no problem in meeting its short term obligations.
AEVA has a better Quick ratio (2.76) than 72.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.88
Quick Ratio 2.76
AEVA Yearly Current Assets VS Current LiabilitesAEVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 31.56% over the past year.
AEVA shows a strong growth in Revenue. In the last year, the Revenue has grown by 95.90%.
AEVA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 45.63% yearly.
EPS 1Y (TTM)31.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.64%
Revenue 1Y (TTM)95.9%
Revenue growth 3Y-0.72%
Revenue growth 5Y45.63%
Sales Q2Q%59.85%

3.2 Future

AEVA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.55% yearly.
Based on estimates for the next years, AEVA will show a very strong growth in Revenue. The Revenue will grow by 112.17% on average per year.
EPS Next Y9.94%
EPS Next 2Y8.64%
EPS Next 3Y10.9%
EPS Next 5Y16.55%
Revenue Next Year95.72%
Revenue Next 2Y127.83%
Revenue Next 3Y146.14%
Revenue Next 5Y112.17%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AEVA Yearly Revenue VS EstimatesAEVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
AEVA Yearly EPS VS EstimatesAEVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 -2 -3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

AEVA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AEVA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AEVA Price Earnings VS Forward Price EarningsAEVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AEVA Per share dataAEVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.64%
EPS Next 3Y10.9%

More info and screens

0

5. Dividend

5.1 Amount

AEVA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AEVA TECHNOLOGIES INC

NASDAQ:AEVA (6/18/2025, 11:00:06 AM)

27.55

+1.73 (+6.7%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners55.55%
Inst Owner Change18.48%
Ins Owners32.12%
Ins Owner Change42.91%
Market Cap1.52B
Analysts81.82
Price Target16.32 (-40.76%)
Short Float %10.73%
Short Ratio1.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.16%
Min EPS beat(2)13.49%
Max EPS beat(2)16.82%
EPS beat(4)4
Avg EPS beat(4)10.65%
Min EPS beat(4)3.98%
Max EPS beat(4)16.82%
EPS beat(8)6
Avg EPS beat(8)3.33%
EPS beat(12)9
Avg EPS beat(12)2.29%
EPS beat(16)9
Avg EPS beat(16)-2.1%
Revenue beat(2)2
Avg Revenue beat(2)24.33%
Min Revenue beat(2)7.15%
Max Revenue beat(2)41.51%
Revenue beat(4)4
Avg Revenue beat(4)19.73%
Min Revenue beat(4)5.04%
Max Revenue beat(4)41.51%
Revenue beat(8)7
Avg Revenue beat(8)12.41%
Revenue beat(12)9
Avg Revenue beat(12)1.02%
Revenue beat(16)12
Avg Revenue beat(16)4.43%
PT rev (1m)144.09%
PT rev (3m)192.64%
EPS NQ rev (1m)4.9%
EPS NQ rev (3m)0.85%
EPS NY rev (1m)0%
EPS NY rev (3m)8.47%
Revenue NQ rev (1m)15.29%
Revenue NQ rev (3m)23.39%
Revenue NY rev (1m)7.94%
Revenue NY rev (3m)19.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 146.79
P/FCF N/A
P/OCF N/A
P/B 22.03
P/tB 22.52
EV/EBITDA N/A
EPS(TTM)-2.06
EYN/A
EPS(NY)-1.78
Fwd EYN/A
FCF(TTM)-2.01
FCFYN/A
OCF(TTM)-1.94
OCFYN/A
SpS0.19
BVpS1.25
TBVpS1.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -132.52%
ROE -220.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-67.52%
ROA(5y)-60.44%
ROE(3y)-87.76%
ROE(5y)-76.12%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 70.94%
Cap/Sales 37.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.88
Quick Ratio 2.76
Altman-Z 7.42
F-Score4
WACC9.1%
ROIC/WACCN/A
Cap/Depr(3y)151.03%
Cap/Depr(5y)257.65%
Cap/Sales(3y)125.12%
Cap/Sales(5y)96.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.64%
EPS Next Y9.94%
EPS Next 2Y8.64%
EPS Next 3Y10.9%
EPS Next 5Y16.55%
Revenue 1Y (TTM)95.9%
Revenue growth 3Y-0.72%
Revenue growth 5Y45.63%
Sales Q2Q%59.85%
Revenue Next Year95.72%
Revenue Next 2Y127.83%
Revenue Next 3Y146.14%
Revenue Next 5Y112.17%
EBIT growth 1Y5.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year23.89%
EBIT Next 3Y11.89%
EBIT Next 5Y7.45%
FCF growth 1Y12.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y10.59%
OCF growth 3YN/A
OCF growth 5YN/A